For example, as reported by Chen et al., TRIM13 was downregulated in esophageal cancer, ovarian cancer, leukemia, especially breast cancer, and lower TRIM13 expression levels were associated with poorer distant metastasis and recurrence‐free survival in breast cancer patients. Here, TRIM13 is linked to breast carcinoma.